Dr Prakash Bhuyan | Vice President, Clinical Development

Dr Prakash Bhuyan, Vice President, Clinical Development, inovio

Dr. Bhuyan heads Inovio’s clinical programs to treat HPV-related precancers as they head in the late stage clinical trials. Dr. Bhuyan has made profound contributions to the field of vaccinology by designing, leading, and providing medical guidance for development programs at multiple companies, successfully leading many vaccine candidates from clinical trials to commercial approval. Dr. Bhuyan is board certified in both Internal Medicine and Adult Infectious Diseases, and serves as adjunct assistant professor at the University of Pennsylvania. Dr. Bhuyan also served as medical lead in the TransCelerate BioPharma-sponsored collaborative—a large control database designed to facilitate the development of new medicines. He earned his M.D. and his Ph.D. in Immunology from the University of Texas Southwestern Medical Center, Medical Scientist Training Program.


Day 3, April 9 @ 12:00

Late stage development of a novel DNA-based immunotherapy to treat cervical dysplasia caused by human papillomavirus (HPV)

last published: 05/Mar/20 10:35 GMT

back to speakers

Sign Up for Event Updates